1. Home
  2. IMNM vs FRSX Comparison

IMNM vs FRSX Comparison

Compare IMNM & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$23.48

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.66

Market Cap

6.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
FRSX
Founded
2006
N/A
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
6.3M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
IMNM
FRSX
Price
$23.48
$1.66
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$26.89
N/A
AVG Volume (30 Days)
1.2M
562.7K
Earning Date
11-06-2025
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,679,000.00
$452,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.15
$1.75
52 Week High
$20.80
$18.41

Technical Indicators

Market Signals
Indicator
IMNM
FRSX
Relative Strength Index (RSI) 70.72 29.07
Support Level $18.81 $1.76
Resistance Level $25.30 $1.90
Average True Range (ATR) 1.47 0.09
MACD 0.26 -0.03
Stochastic Oscillator 74.79 11.29

Price Performance

Historical Comparison
IMNM
FRSX

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: